Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A Yemeni pro-government solider in an industrial district of the port city of Hodeidah on November 18, 2018. Photo: Stringer/AFP/Getty Images

As the war in Yemen grinds toward its fourth year, the prospects may be improving for a deal to reduce the bloodshed and suffering.

Why it matters: Yemen is facing a terrible humanitarian crisis — potentially the world’s worst in the past century — with as many as half of its 28 million people at risk of starvation, according to UN estimates. The conflict has allowed al-Qaeda’s most dangerous branch to deepen its influence within Yemen and has also spilled over the country’s borders, with regular Houthi drone and missile strikes in Saudi Arabia.

Details: The U.S. Senate’s vote this week to consider cutting support to the Saudi military campaign is the latest sign of momentum toward ending the conflict. On Thursday, the Houthis agreed to attend peace talks in Sweden next week if their safe passage is guaranteed.

  • Houthi leaders undoubtedly recognize that they will eventually lose the fight for Hodeidah to the Saudi-led coalition, and may calculate that it would be wise to cut a deal before they lose access to the port’s critical resources.

The Saudis, meanwhile, are under intense international pressure in the wake of Jamal Khashoggi’s murder. The potential loss of U.S. military support is likely to generate a newfound willingness on their part to negotiate in earnest.

  • The Emiratis, who following the bloody fight for Hodeidah likely want to avoid participating in a ground assault on Houthi strongholds in the north, and the Iranians, who provide military support to the Houthis but face their own domestic and international pressures, may be similarly receptive to talks.

What’s next: If UN envoy Martin Griffiths is able to bring together the Saudi-backed Yemen government and the Houthis in Sweden next week, those negotiations will present the best opportunity to achieve progress toward ending, or at least easing, the conflict.

  • Immediate measures to discuss include a “freeze for freeze” on missile and airstrikes, the creation of cease-fire zones to facilitate the flow of humanitarian aid, and cash injections to prop up Yemen’s devastated banking system.

The bottom line: A rare window of opportunity has opened for a settlement, even if it may not meet each party’s maximalist objectives. For the long-suffering people of Yemen, such a deal is overdue and certainly worth making.

Michael P. Dempsey is the national intelligence fellow at the Council on Foreign Relations, a government-sponsored fellowship. He is the former acting director of national intelligence and the opinions expressed are his alone.

Go deeper

Ben Geman, author of Generate
37 mins ago - Energy & Environment

Democrats' clean power outlook is very muddy

Illustration: Annelise Capossela/Axios

Here are two big questions as a key Democratic proposal to slash emissions from power generation flounders: how much its demise would sap climate protections, and what might replace it.

Catch up fast: New financial carrots and sticks for utilities to deploy zero-carbon power — the Clean Electricity Performance Program (CEPP) — look unlikely to stay in Democrats' big social spending and climate bill.

Colin Powell dies from COVID complications at 84

Photo: Paul Morigi/Getty Images for Capital Concerts

Colin Powell, the first Black U.S. secretary of state, died of complications from COVID-19, his family announced Monday. He was 84.

Driving the news: The Powell family said in a statement that he was fully vaccinated. "We want to thank the medical staff at Walter Reed National Medical Center for their caring treatment."

3 hours ago - Health

This arthritis drug cost $198 in 2008. Now it's more than $10,000

Illustration: Aïda Amer/Axios

In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.

Why it matters: As federal lawmakers continue to waver on drug price reforms, Indocin is another example of how nothing prevents drug companies from hiking prices at will and selling them within a broken supply chain.